BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34218422)

  • 21. Monitoring indices of bone inflammatory activity of the jaw using SPECT bone scintigraphy: a study of ARONJ patients.
    Hata H; Kitao T; Sato J; Asaka T; Ohga N; Imamachi K; Hirata K; Shiga T; Yamazaki Y; Kitagawa Y
    Sci Rep; 2020 Jul; 10(1):11385. PubMed ID: 32647190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonexposed antiresorptive agent-related osteomyelitis of the jaw: a single-center cohort study.
    Watanabe T; Yoshida T; Akizuki S; Yamanaka S; Nakao K; Fukuhara S; Asai K; Uozumi R; Bessho K
    J Bone Miner Metab; 2022 Jul; 40(4):657-662. PubMed ID: 35534635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and risk of antiresorptive agent-related osteonecrosis of the jaw (ARONJ) after tooth extraction in patients with autoimmune disease.
    Fujieda Y; Doi M; Asaka T; Ota M; Hisada R; Ohnishi N; Kono M; Kameda H; Nakazawa D; Kato M; Amengual O; Takahata M; Yasuda S; Kitagawa Y; Atsumi T
    J Bone Miner Metab; 2020 Jul; 38(4):581-588. PubMed ID: 32076874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osteonecrosis of the jaw in patients transitioning from bisphosphonates to denosumab treatment for osteoporosis.
    Voss PJ; Steybe D; Poxleitner P; Schmelzeisen R; Munzenmayer C; Fuellgraf H; Stricker A; Semper-Hogg W
    Odontology; 2018 Oct; 106(4):469-480. PubMed ID: 29713913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Incidence of Antiresorptive Agent-Related Osteonecrosis of the Jaw in Urologic Cancers].
    Kawanishi H; Yokozeki H; Hoshiyama A; Watanabe H; Funahashi Y; Fujiwara M; Takashima Y; Shintani M; Yui S; Okumura K
    Hinyokika Kiyo; 2022 Jan; 68(1):1-6. PubMed ID: 35114759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A Case Report of Kampo Medicine Improving the Symptoms of Antiresorptive Agent-related Osteonecrosis of the Jaw (ARONJ)].
    Yamazaki Y; Shimada M
    Yakugaku Zasshi; 2021; 141(9):1123-1127. PubMed ID: 34471013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experience with the treatment of bisphosphonate-related osteonecrosis of the jaw.
    Janovska Z; Mottl R; Slezak R
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):313-7. PubMed ID: 24108250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes.
    O'Ryan FS; Lo JC
    J Oral Maxillofac Surg; 2012 Aug; 70(8):1844-53. PubMed ID: 22595135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinctive role of 6-month teriparatide treatment on intractable bisphosphonate-related osteonecrosis of the jaw.
    Kim KM; Park W; Oh SY; Kim HJ; Nam W; Lim SK; Rhee Y; Cha IH
    Osteoporos Int; 2014 May; 25(5):1625-32. PubMed ID: 24554340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is the conservative non-surgical management of medication-related osteonecrosis of the jaw an appropriate treatment option for early stages? A long-term single-center cohort study.
    Ristow O; Rückschloß T; Müller M; Berger M; Kargus S; Pautke C; Engel M; Hoffmann J; Freudlsperger C
    J Craniomaxillofac Surg; 2019 Mar; 47(3):491-499. PubMed ID: 30642734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraindividual comparison of preoperative (99m)Tc-MDP SPECT/CT and intraoperative and histopathological findings in patients with bisphosphonate- or denosumab-related osteonecrosis of the jaw.
    Assaf AT; Zrnc TA; Remus CC; Adam G; Zustin J; Heiland M; Friedrich RE; Derlin T
    J Craniomaxillofac Surg; 2015 Oct; 43(8):1461-9. PubMed ID: 26232916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluorodeoxyglucose positron emission tomography with computed tomography detects greater metabolic changes that are not represented by plain radiography for patients with osteonecrosis of the jaw.
    Fleisher KE; Raad RA; Rakheja R; Gupta V; Chan KC; Friedman KP; Mourtzikos KA; Janal M; Glickman RS
    J Oral Maxillofac Surg; 2014 Oct; 72(10):1957-65. PubMed ID: 25053572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stage-specific therapeutic strategies of medication-related osteonecrosis of the jaws: a systematic review and meta-analysis of the drug suspension protocol.
    Ramaglia L; Guida A; Iorio-Siciliano V; Cuozzo A; Blasi A; Sculean A
    Clin Oral Investig; 2018 Mar; 22(2):597-615. PubMed ID: 29332231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Staging of osteonecrosis of the jaw requires computed tomography for accurate definition of the extent of bony disease.
    Bedogni A; Fedele S; Bedogni G; Scoletta M; Favia G; Colella G; Agrillo A; Bettini G; Di Fede O; Oteri G; Fusco V; Gabriele M; Ottolenghi L; Valsecchi S; Porter S; Petruzzi M; Arduino P; D'Amato S; Ungari C; Fung Polly PL; Saia G; Campisi G
    Br J Oral Maxillofac Surg; 2014 Sep; 52(7):603-8. PubMed ID: 24856927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update MRONJ and perspectives of its treatment.
    Voss PJ; Poxleitner P; Schmelzeisen R; Stricker A; Semper-Hogg W
    J Stomatol Oral Maxillofac Surg; 2017 Sep; 118(4):232-235. PubMed ID: 28697987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of the maxillary sinus in bisphosphonate-related osteonecrosis of the jaw: Radiologic aspects.
    Wasserzug O; Kaffe I; Lazarovici TS; Weissman T; Yahalom R; Fliss DM; Yarom N
    Am J Rhinol Allergy; 2017 Jan; 31(1):36-39. PubMed ID: 28234151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of bisphosphonates on healing of tooth extraction wounds in infectious osteomyelitis of the jaw.
    Yamashita J; Sawa N; Sawa Y; Miyazono S
    Bone; 2021 Feb; 143():115611. PubMed ID: 32829042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disease Stage and Mode of Therapy Are Important Determinants of Treatment Outcomes for Medication-Related Osteonecrosis of the Jaw.
    Ruggiero SL; Kohn N
    J Oral Maxillofac Surg; 2015 Dec; 73(12 Suppl):S94-S100. PubMed ID: 26608159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral risk factors associated with medication-related osteonecrosis of the jaw in patients with cancer.
    Ueda N; Aoki K; Shimotsuji H; Nakashima C; Kawakami M; Imai Y; Kirita T
    J Bone Miner Metab; 2021 Jul; 39(4):623-630. PubMed ID: 33420576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.
    O'Ryan FS; Khoury S; Liao W; Han MM; Hui RL; Baer D; Martin D; Liberty D; Lo JC
    J Oral Maxillofac Surg; 2009 Jul; 67(7):1363-72. PubMed ID: 19531404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.